The Goldilocks Approach: A Review of Employing Design of Experiments in Prokaryotic Recombinant Protein Production by Uhoraningoga, Albert et al.
Technological University Dublin 
ARROW@TU Dublin 
Articles School of Food Science and Environmental Health 
2018-10-18 
The Goldilocks Approach: A Review of Employing Design of 
Experiments in Prokaryotic Recombinant Protein Production 
Albert Uhoraningoga 
Technological University Dublin, c12712219@mytudublin.ie 
Gemma K. Kinsella 
Dublin inst, gemma.kinsella@tudublin.ie 
Gary T. Henehan 
Technological University Dublin, gary.henehan@tudublin.ie 
Barry Ryan 
Technological University Dublin, barry.ryan@tudublin.ie 
Follow this and additional works at: https://arrow.tudublin.ie/schfsehart 
 Part of the Biochemistry, Biophysics, and Structural Biology Commons, Bioinformatics Commons, 
Biology Commons, Pharmacology, Toxicology and Environmental Health Commons, and the Physical 
Sciences and Mathematics Commons 
Recommended Citation 
Uhoraningoga, A., Kinsella, G., Henehan, G. and Ryan, B. (2018) The Goldilocks Approach: A Review of 
Employing Design of Experiments in Prokaryotic Recombinant Protein Production. Bioengineering 2018, 5, 
89; doi:10.3390/bioengineering5040089 
This Article is brought to you for free and open access by 
the School of Food Science and Environmental Health at 
ARROW@TU Dublin. It has been accepted for inclusion in 
Articles by an authorized administrator of ARROW@TU 
Dublin. For more information, please contact 
yvonne.desmond@tudublin.ie, arrow.admin@tudublin.ie, 
brian.widdis@tudublin.ie. 
This work is licensed under a Creative Commons 
Attribution-Noncommercial-Share Alike 3.0 License 
bioengineering
Review
The Goldilocks Approach: A Review of Employing
Design of Experiments in Prokaryotic Recombinant
Protein Production
Albert Uhoraningoga, Gemma K. Kinsella, Gary T. Henehan and Barry J. Ryan *
Dublin Institute of Technology, Dublin D01 HV58, Ireland; C12712219@mydit.ie (A.U.);
Gemma.Kinsella@dit.ie (G.K.K.); Gary.Henehan@dit.ie (G.T.H.)
* Correspondence: Barry.Ryan@dit.ie; Tel.: +353-1-402-4379
Received: 20 September 2018; Accepted: 12 October 2018; Published: 19 October 2018


Abstract: The production of high yields of soluble recombinant protein is one of the main objectives
of protein biotechnology. Several factors, such as expression system, vector, host, media composition
and induction conditions can influence recombinant protein yield. Identifying the most important
factors for optimum protein expression may involve significant investment of time and considerable
cost. To address this problem, statistical models such as Design of Experiments (DoE) have been used to
optimise recombinant protein production. This review examines the application of DoE in the production
of recombinant proteins in prokaryotic expression systems with specific emphasis on media composition
and culture conditions. The review examines the most commonly used DoE screening and optimisation
designs. It provides examples of DoE applied to optimisation of media and culture conditions.
Keywords: recombinant protein production; design of experiments; screening design; response
surface methodology; process optimization
1. Introduction
Advances in biotechnology, including the development of genetic engineering and cloning,
have provided a means for the large scale expression of heterologous proteins for different
applications [1]. Currently, recombinant proteins are widely used in the biological and biomedical
industries as well as in research with their market share increasing rapidly [2,3]. The production of high
yields of soluble and functional recombinant protein is the ultimate goal in protein biotechnology [4].
To achieve this objective, many key aspects such as the expression system, the expression vector,
the host strain, the purification tag, the media composition, the induction conditions and the
purification methods need to be carefully evaluated and optimised before embarking on large scale
production of a recombinant protein of interest [5–7].
Although both eukaryotic and prokaryotic expression systems are used for overproduction of
soluble recombinant protein, choosing the right system for your protein depends, amongst other things,
on the growth rate and culturing conditions of host cells, the level of the target gene expression and
post translational processing of the synthesized protein [8,9]. The most commonly used prokaryotic
systems are based on expression in bacteria, including E. coli and Bacillus species [10,11]. There is no
single method which is universally successful for protein expression that will ensure the production of
a desired concentration of soluble and functional protein [12–14]. Varying factors that influence
protein expression in a trial-and-error process to achieve optimum protein expression has been
troublesome [15]. To overcome this problem, statistical approaches have been used to evaluate the
variables that have the largest influence on the production of a recombinant protein of interest in terms
of yield [16,17], product quality [18], purity [19,20] and solubility [21,22]. These statistical processes
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include the Design of Experiment (DoE) approach [23,24]. This approach advances the traditional
one-factor-at-a-time (OFAT) method, which involves varying one factor while other factors are held
constant. This single variable OFAT approach results in the need to run multiple experiments with
a high risk of failing to identify the true optimum [25]. The DoE method provides for a significantly
reduced experimental matrix [26–28].
There are an increasing number of published studies on the application of statistically based
optimization processes in the field of protein biotechnology [18,29]. This has been matched by a
corresponding increase in the application of DoE methods, such as screening and optimisation designs,
to enhance protein production. This review examines the literature on the DoE methodologies
commonly employed to evaluate the effect of media composition and culture conditions on
recombinant protein expression. It will focus on the application of DoE to increase recombinant
protein expression in prokaryotic systems, where high yields can be achieved but poor product quality
remains a risk [30]. It also provides an overview of the important statistical analysis tools embedded in
common DoE software. These tools facilitate the interpretation of experimental data which ultimately
allows the identification of optimal factor levels for maximum yield. Finally, the review provides
some thoughts on the benefits of the common DoE methods typically used in recombinant protein
production in order to direct future research efforts.
2. Production of Recombinant Proteins in a Prokaryotic Expression System
2.1. Factors that Inform the Choice of Expression System
Protein purification from natural sources can require a large quantity of the source organism and
may yield only small amount of target protein after several rounds of extraction and purification [4,31].
Recombinant expression of proteins has become an indispensable tool to produce proteins to
satisfactory yields [32] and to meet the demands of industry and research [1,33]. With the aid of
genetic engineering, a desired gene cloned into a suitable expression vector can be overexpressed
as a recombinant protein of interest [34]. Recombinant proteins can be expressed in cell cultures of
bacteria [35], yeasts [36], mammalian cells [37,38], plants [39] and insects [40]. However, the prokaryotic
systems remains the most attractive hosts due to their low cost, high productivity and rapid production
rates [30]. Prokaryotic heterologous protein expression is mainly carried out in the bacteria E. coli,
although increasingly the Bacillus species are being employed [41–43]. Drawbacks of prokaryotic
expression systems include poor protein quality, due to the inability of prokaryotic cells to carry out
post-translational modifications such as glycosylation, the presence of toxic cell wall pyrogens, along
with the formation of inclusion bodies resulting in aggregated and insoluble heterologous protein [44].
Some widely used bacterial expression systems that are commercially available are listed in Table 1.
Table 1. Summary of the most widely used recombinant expression strains from E. coli and Bacillus
species outlining their advantages and disadvantages.
General Advantages Disadvantages References
Most common E. coli strains
Rapid expression, high yield, ease of
culture and gene modification,
cost effective.
Post translational modification
not possible.
Inclusion body formation
[41,45,46]
BL21,
B21-Codonplus (RIL),
BL21(DE3),
BL21(DE3)pLys S/E,
BL21 Star, C41(DE3), C43(DE3), Codon plus (RP),
Lemon21(DE3), M15, Origami, Rosetta, SG13009,
Shuffle Derivatives of K-12, AD494 and HMS174.
Most common Bacillus species
Bacillus brevis, Bacillus megaterium and Bacillus subtilis.
Preferred for homologous expression
of some enzymes (e.g., proteases
and amylases),
Strong secretion, no involvement of
intracellular inclusion bodies and ease
of manipulation.
Contains proteases, which
may hydrolyse recombinant
proteins.
[42,47–50]
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While there are a variety of expression vectors commercially available, their choice is strongly
based on the combination of replicons, promoters, selection markers, multiple cloning sites and
fusion proteins [11]. An informed decision on the best expression plasmid [10,51–54] can be
confusing. The most commonly used expression plasmids [22,55–58] and their key features such
as promoters [59–63], affinity tags [64,65] and selection markers [7] have been extensively reviewed in
the literature, primarily focusing on the E. coli prokaryotic expression system. Widely used Bacillus
strains [66,67], vectors and promoters have also been reviewed [68–70].
2.2. Factors that Influence Media Composition and Culture Conditions in an Expression System
A careful selection of expression system, expression vector and host does not always guarantee
the production of a large amount of target protein in soluble and active form [7]. Media composition
and induction conditions have a significant influence on recombinant protein expression levels [71–73]
and solubility [45]. For example, media containing a defined concentration of salts, peptone and yeast
influences the yield of a recombinant glucosidase [47]; while media composition does not always
have a major effect on protein solubility [51]. Prosthetic groups in media are known to prevent the
formation of inclusion bodies [74] where required by the protein [41,75]. The most common media
used in prokaryotic expression systems, along with their advantages and disadvantages, have been
reviewed elsewhere [76]. Culture conditions are another set of factors that must be carefully optimised
to achieve high yields of heterologous protein [14]. Factors such as cell density prior to induction,
inducer concentration, induction temperature and induction duration are all known to influence
yield [77–81].
2.3. Enhancing the Production of Recombinant Proteins in a Prokaryotic Expression System by DoE
It can be difficult to make informed decisions regarding the optimal combination of expression
system, conditions and media components. Oftentimes this results in an unsatisfactory and costly
trial-and-error process being employed to enhance the overall production yield [64]. To address this
problem more effective, statistically supported, approaches have been developed and have gained
significant traction. In this approach, a controlled model is developed defining media components,
induction and expression conditions based on the recombinant protein of interest [16]. DoE, employed
in this way, has provided powerful tools to screen and optimise factors affecting recombinant protein
expression [82]. This is due to DoEs’ ability to identify factors affecting recombinant protein production
and optimise the process with the minimum number of experiments [83]. A typical DoE workflow is
depicted in diagrammatic form (see Figure 1). The desired output, or response, is to achieve a high
yield of a protein of interest and involves three main stages:
Stage 1. The first stage of the process is to compile a list of factors that can influence protein expression. These are
usually such factors as; induction temperature, induction duration, pH, media components (carbon source,
nitrogen source, micronutrients).
Stage 2. At this stage, a suitable software package such as MINITAB, JMP or Design Experts will be acquired
for the statistical analysis. The second stage of DoE aims to reduce the number of factors to a smaller subset,
these being the most important factors (i.e. those with the greatest impact on expression). This process is known
as screening. Having a smaller set of significant factors greatly simplifies the statistical process. Sometimes,
if the number of factors is small (between 2 and 4) there is no need to carry out the screening stage. When looking
at a factor that influences protein expression the concept of levels is important: temperature, for example, may be
examined between 20 ◦C and 40 ◦C. These two temperatures represent the lowest and highest “level” of this
parameter that will influence expression. For the purposes of modelling these two levels are input into the model
for this factor. Similarly, the upper and lower levels are input for all other relevant parameters. It is important to
note that the levels are input into the DoE package as +1 (highest value of a parameter) and −1 (lowest value of a
parameter). This “coding” is carried out to avoid the use of multiple different measurement units for parameters
such as pH, temperature. The software will then suggest a minimal set of experiments to explore the significance
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of each factor. The design of the experimental matrix can be selected from a range of choices such as Full Factorial
Design, Plackett Burman Design or indeed a custom design. The objective is to assess the “main effect” of a
factor (its direct effect on a response) as well as its “interaction effects” (the effect on other factors). The suggested
experiments are carried out and the results are used to inform the next stage of the process—optimisation.
Stage 3. The final stage of the process is optimisation and is typically carried out with a set of three to four
factors. An experimental RSM (Response Surface Methodology) design strategy is selected and experiments are
run as for the screening stage. The optimisation process expresses the response surface as a polynomial and uses
the input data to estimate its coefficients. The derivative of this polynomial is used to obtain inflection points
corresponding to maxima or minima in the model. The model can be evaluated by looking at the goodness of fit
between the model and experimental data. Finally, experiments using the optimum conditions predicted by the
model are carried out to validate the model.
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further optimisation. A Box-Benkhn Design (BBD) also under RSM was selected to optimize the 
screened factors and increased the production of human interferon-γ up to 5.1 fold. Further details of 
these two case studies can be found in the references provided and similar cases are found in Tables 
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Figure 1. typical oE orkflo in protein production. Case study illustrates the opti ization of
recombinant lipase KV1 expression in E. coli [84] where a screening process was not required since the
number of factors affecting this enzyme is not large (four fact rs). The four factors (A, B, C, D), therefore,
underwent optimisation by Central Composite Design (CCD) under Response Surface Methodology
(RSM) which resulted in a yield increase in protein expression of 3.1-fold. Case study B escribes the
optimisation process for high yield production of recombinant human interferon-γ [85]. In this case,
the number of factors involved is large (nine factors) and they were subjected to a screening process
before optimisation. Four factors (X1, X2, X3, X7) out of nine were identified by Plackett-Burman
Design (PBD) based screening to be the most influential and subsequently used for further optimisation.
A Box-Benkhn Design (BBD) also under RSM was selected to optimize the screened factors and
increased the production of human interferon-γ up to 5.1 fold. Further details of these two case studies
can be found in the references provided and similar cases are found in Tables 4 and 7.
3. Design of Experiments (DoE) to Optimise Recombinant Protein Production
3.1. DoE; a Brief Overview
DoE is a statistical technique used to plan experiments and analyse data using a controlled set
of tests designed to model and explore the relationship between factors and observed responses [14].
This technique allows the researcher to use the minimum number of experiments, in which the
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experimental parameters can be varied simultaneously, to make evidence based decisions [86].
It uses a mathematical model to analyse the process data, such as protein expression levels [87].
The model allows a researcher to understand the influence of the experimental parameters (inputs)
on the response (outputs) and to identify a process optimum [88]. Furthermore, DoE software uses
three-dimensional surface and contour plots, to visualise and understand the relationship between
factors and responses [55,89]. In recombinant protein production, a DoE approach can significantly
improve the efficiency in screening for most influential experimental parameters (e.g., media
composition, culture condition etc.) and determine optimal experimental conditions [90].
The mathematical models employed in DoE define the process under study [91]. Screening
designs such as Plackett Burman Design are based on a first order model [92] as shown in Equation (1).
Y = β0 + ΣβiXi (1)
where Y is the response, β0 is the model intercept, βi is the linear coefficient and Xi is the level of the
independent variables. A statistically significant level of 5% (p-value = 0.05) is commonly used to
identify the most influential factors. The significance level (or p-value) of each variable is based on its
effect on the response and is calculated using Student’s T-test [85] in Equation (1).
txi =
E(Xi)
S.E.
(2)
where E(Xi) is the effect of variable Xi and S.E., the associated standard error. Factors with
p-value < 0.05 are statistically significant while factors with p-value > 0.05 are not statistically significant
(see Table 5 for more details). Statistically significant factors are subjected to further optimisation by
Response Surface Methodology. A second-order polynomial equation in which independent variables
are coded using Equation (3) is used to input factors into the model (see Section 5.4).
xi =
(
Xi− Xcp
)
∆Xi
, i = 1, 2, 3 . . . k (3)
where xi is a dimensionless value of an independent variable; Xi is real value of an independent
variable; Xcp is real value of an independent variable at the design centre point; and ∆Xi is step change
in the real value of the variable i [93]. Replicates at the central point are required to check for the
absence of bias between sets of experiments. The fit of the model is then evaluated through analysis of
variance (ANOVA) which determines the significance of each term in the equation and estimates the
goodness of fit in each case [94] (see Figure 5 and Table 9 for more details).
3.2. DoE Versus One-Factor-At-a-Time (OFAT)
DoE advances the traditional OFAT approach; OFAT fails to account for variables interacting
with and influencing, each other and also requires significantly more experiments to converge on an
optimum; all of which increases cost and time [95]. Figure 2 provides a brief comparative description
between DoE and OFAT.
In recombinant protein expression, where various independent variables do not always act in
isolation, it is likely that their interaction effects can significantly influence protein production [96].
Therefore, it is necessary to use a controlled set of tests that can examine the effects of many interacting
factors to achieve optimal expression [97].
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using more experiments than DoE (each black dot represents an experiment) and does not identify
the true optimum (indicated as a red oval). However, with the DoE approach (b) fewer experiments
are used and the likelihood of finding the optimum conditions (in red) for the process being studied
is high. ith DoE the combined or interaction effect of P1 and P2 on the response can be identified
and measured. The ovals indicate production yields, blue indicates the lowest yields, whereas red
indicates highest yields, where the opti u is found. The DoE approach also identifies a pathway to
the opti u response (indicated by the arro ).
. efi i r fl t ti ise ec i a t rotei roduction
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r tei r cti [ ]. The second step in the orkflo is t se ti is ti esi t
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si . A variety of DoE software p ckages such as MINITAB (Minitab Ltd., State College, PA,
USA), JMP (SAS Institute, Cary, NC, USA) and Design Experts (Science Plus Group, Groningen,
the Netherlands) are commerci lly vail ble and provide a variety of f ctorial designs epending
upon the objectiv of the experiment. Regardless of the statistic l package used, the main steps of a
typical DoE orkflow include planning the t st, screening and optimisation (detailed schematically in
Figure 3).
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5. A Suggested DoE Workflow for Recombinant Protein Production
5.1. Planning the Test; Selection of Factors and Associated Levels Influencing Recombinant Protein Production
The DoE workflow in protein production, like in any other DoE process optimisation, starts with
the planning the test [99]. This involves defining the objective of the study, identifying factors involved
and associated levels (i.e., high, central and low). Thus, preliminary experiments are recommended
when knowledge of effects of factors on the experiment is not sufficient to set levels. The factors are
input parameters that can be modified in the experiment and are referred to as the controllable factors.
The levels of factors are fixed based on their working limits [82]. The most popular experimental
designs are two level designs although more levels can be used depending upon the type of design
and objective of the study. Table 2 depicts a two level experimental design.
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Table 2. An example of a two level experimental design having nine factors that are known to influence
recombinant protein expression. In this case the nine factors relate to two experimental components;
media composition and induction conditions. When planning the screening phase the selected factors
(yeast extract, tryptone, glycerol, NaCl, Inoculum size, IPTG concentration, induction temperature,
incubation time and pH, labelled X1 to X9 respectively) and associated levels (high, defined as +1 and
low defined as −1 are selected to cover the intended experimental space (i.e., to cover the productive
range). The levels are defined as the range between the known working limits.
Factors
Levels
Low High
Media composition
X1 Yeast Extract − +
X2 Tryptone − +
X3 Glycerol − +
X4 NaCl − +
Induction condition
X5 Inoculum size − +
X6 IPTG concentration − +
X7 Induction temperature − +
X8 Incubation time − +
X9 pH − +
In general, for recombinant protein expression subjected to DoE, the most commonly selected
factors relate to media composition and include components such as yeast extract [100], K2HPO4,
MgSO4, starch, glucose, peptone, NaCl, sucrose, glycerine [101]. For induction conditions, common
factors selected are incubation time, incubation temperature, pH, agitation, inoculum age and
size [102,103]; induction period, induction temperature, culture inoculation concentration [48,104];
Optical Density (OD), Isopropyl β-D-1-thiogalactopyranoside (IPTG) concentration [21].
5.2. Screening Designs to Identify Factors that Significantly Affect Recombinant Protein Expression
Screening designs are used to devise a matrix using factors and levels as formulated in the
planning stage. [105]. By employing the statistical tools embedded in the DoE software, screening
designs establish the relationships between variables and responses. The interaction effects between
variables on a given response are also investigated [106]. In protein biotechnology, screening designs
are mainly utilised to identify media composition and culture condition factors that significantly
influence protein production [107]. Various researchers have explored the effects of both media
components [94,107–110] and culture conditions [111,112] on protein expression. There are many
different types of screening designs and their choice depends upon the nature of experiment and
the objective of the study. The classical screening designs include Full Factorial Designs, Fractional
Factorial Designs and Plackett-Burman Designs. Current DoE software, such as JMP from the SAS
Institute, provides additional screening designs such as Definitive Screening Designs and Custom
Designs. The most common screening designs are compared in Table 3.
5.2.1. Full Factorial Design
When little is known about the effects of the factors on a response, a full factorial design is
recommended. This design includes all combinations of all factor levels and provides a predictive
model that includes the main effects and all possible interactions [113]. This design consists of two,
or more, levels with experimental runs that encompass all possible combinations of these levels,
across all factors. In a full factorial design where k represents number of factors; 2k represents the
number of experiments required to carry out a two level design with k factors. Similar to other
screening designs, Full Factorial Design can include centre points, randomisation and blocking
variables to improve the efficiency of the design [14]. This approach was significant in screening for
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the most influential factors affecting recombinant protein production for a variety of proteins [114,115]
(see Table 4).
Table 3. A comparison of DoE screening designs commonly used in optimizing recombinant protein
production. The table lists the types of screening designs; the effect explained by the model along with
number of factors and associated number of runs (a rune refers to an experiment). It should be noted
that extra runs (such as those related to central points) can be added when required. Custom design is
more flexible and allows the designer to select the number of experimental runs.
Factors
Number of Runs
Screening Design Effect explained by the model 2 3 4 5 6 7
Full Factorial Design Main effect and 2 factor interactions 4 8 16 32 64 128
Fractional Factorial
Design
Main effect only - - - 8 8 8
Main effect and 2 factor interactions - 8 8 16 16 16
Main effect and 2 factors interactions - - 16 16 32 64
Plackett-Burman
Design Main effect only - - - - 12 12
Definitive Screening
Design
Main effect and 2 factor interaction - 13 13 13 13 17
Main effect, 2 factor interaction and
quadratic effects - 17 17 17 17 22
Custom Design Main effect only ≥3 ≥4 ≥5 ≥6 ≥7 ≥8
5.2.2. Fractional Factorial Design (FFD)
FFD is a recommended screening design when a large number of factors are involved. This design
consists of reducing the initially large number of potential factors to a subset of the most effective ones
and is represented using the following notation:
2
k− p
R
where 2 represents number of levels, k the number of factors, p the extra columns required and R the
resolution of the method. The method resolution describes the degree to which the estimated main
effects are aligned with the estimated interactions associated with levels [22,116,117].
5.2.3. Plackett-Burman Designs (PBD)
PBD design is often used as an alternative to fractional and full factorial designs because of its
potential to reduce the gaps found in fractional designs and to strengthen the estimation of the main
effects, which may have been disregarded when full factorial designs are used [118–122].
5.2.4. Definitive Screening Design (DSD) and Custom Design (CD)
DSD and CD are a class of screening designs that have potential applications in recombinant
protein expression for assessing the impact of a large number of factors on a given response. DSD has
recently been reported to be particularly advantageous as it allows the estimation of the main effects
of certain components alone but also the interactions between components as well as the factors with
non-linear effects such as quadratic effects (an interaction term where a factor interacts with itself);
all executed with the minimum number of experimental runs [123]. CD enables tailoring a design,
whilst simultaneously minimising resource usage: it is highly flexible and more cost-effective than
other screening designs. It allows for the best use of the experimental budget and tackles a wide range
of challenges with the capability to model effects including centre points and replicates. However,
in most cases this design allows for the estimation of main effects only. Table 4 summarises the most
common screening designs, along with their roles in identifying most influential independent factors,
in recombinant protein production.
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Table 4. A selection of the widely used screening designs and their application in identifying the
influential factors on the production of recombinant proteins.
Host Organism Protein Involved Screening Design Factors Studied ScreenedSignificant Factors Reference
Bacillus I-1018 Xylanase Full Factorial Design Media composition Xylan, caseinhydrolysate, NH4Cl
[114]
E. coli Non-structuralprotein NS3 Full Factorial Design Culture condition
temperature,
induction length [124]
Pseudoalteromonas
IND11 Fibrinolytic enzyme Full Factorial Design Media composition
pH, maltose and
NaH2PO4
[115]
E. coli Zinc-metalloprotease(SVP2)
Fractional Factorial
Design
Media composition
and culture
condition
IPTG and Ca2+ ion
concentration and
temperature
[22]
E. coli Soluble pneumolysin Fractional FactorialDesign
Media composition
and culture
condition
Temperature,
tryptone and
kanamycin
[6]
Bacillus cerius L-asparaginase Plackett-Burman Media composition
Soya bean meal,
asparagine,
woodchips, NaCl
[122]
E. coli Vascular endothelialgrowth factor
Plackett-Burman
design
Media composition
and culture
condition
Glycerine, inducing
time, peptone [125]
P. aeruginosa L-asparaginase Plackett-BurmanDesign Culture condition
pH, casein
hydrolysate and corn
steep liquor
[126]
P. pastoris Human interferongamma
Plackett-Burman
Design Media composition
Gluconate, glycine,
KH2PO2
[85]
S. griseorubens Chitinase Plackett–BurmanDesign Media composition
Yeast extract and
K2HPO4, KH2PO4
[127]
Table 5. Identification of the statistically significant factors during a screening process using a Fractional
Factorial Design. The table depicts the effect, positive or negative and p-value for seven factors
examined (labelled X1 to X7 respectively). The effect of each factor, positive (+) or negative (−) is
identified during the analysis stage using the statistical formula imbedded in DoE software used
(JMP in this example). Interaction effects are also identified (e.g., X5*X1 and X3*X7; where * indicates
an interaction). The p-value of each factor is also shown, at the significance level of 0.05. In this
example, the highlighted factors, (X3, X6, X1), were identified as the most influential based on their
high effects (−1.11273, 0.2252, 0.17492) and p-values < 0.05 (0.001, 0.0143, 0.0296). Thus, only factors
X3, X6 and X1 are statistically significant at the level of 0.05, with X3 having a negative effect while
X6 and X1 have positive effects. Other factors, X2, X4, X5, X7 and interactions X5*X1, X3*X7 are not
statistically significant.
Factor Effect Relative Effect p-Value
X3 −1.11273
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The rationale of screening designs lies in identifying the variables that are statistically significant
in influencing protein production among a large number of potentially important variables [128,129].
Table 5 illustrates how screening analysis identifies statistically significant factors based on their effect
and probability values.
The screening process identifies most influential factors on the process under investigation (i.e., X1
and X6 in the example shown in Table 5) and thus paves the way for effective optimisation by reducing
the number of factors to be optimised in the third work package of the DoE workflow [130].
5.3. Optimisation Designs to Maximise Recombinant Protein Production in Prokaryotic Systems
As a collection of statistical design and numerical optimisation techniques [131], optimisation uses
the reduced number of variables identified in the previous screening process and focuses on finding
the variable levels that result in an optimal yield [132,133]. Figure 4, describes the benefit of carrying
out an optimisation process after a screening process has identified a small number of key variables.
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Figure 4. A comparative illustration of screening and optimisation designs. (a) In screening designs a
large number of factors, with reduced number of runs, are used to screen for important factors affecting
the process. (b) In optimisation designs, a reduced number of factors, with large number of runs, are
utilised to find the optimum conditions for high yield of recombinant protein.
Response Surface Methodology (RSM) is the most popular optimisation method [134]. It consists
of mathematical and statistical techniques used to build empirical models capable of exploring the
process space and studying the relationship between the response and process variables to find
the optimal response [99,133,135]. In general, for a given number of factors, RSM requires more
runs than screening designs, thus, the number of factors to consider should initially be reduced
through an appropriate screening process. Central composite designs (CCD) and Box-Behnken designs
(BBD) are the two of the major Response Surface Designs commonly used in recombinant protein
optimization [136].
5.3.1. Central Composite Design (CCD)
CCDs are favoured in process optimisation due to determine the coefficients of a second-degree
polynomial which fit a full quadratic during response surface analysis [127]. CCD has been widely used
in optimising protein production process specifically addressing the aim of increasing productivity
and solubility [137]. There are different types of central composite designs such as uniform precision,
orthogonal/block and so forth. However, a common standard characteristic includes the number of
runs per design [138], which depends on the number factors (see Table 6). Central composite uniform
precision designs are used to provide protection against bias in the regression coefficients while central
composite orthogonal designs can be used to avoid correlations between coefficients of variables [139].
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Table 6. Common CCD components and the possible total number of runs. Factorial, axial and central
points are the main components of a typical CCD and the total number of runs is dictated by the
number of factors being tested. As the number of factors increases, the number of component points
increase and so the total number of runs. In some cases, CCDs do not contain axial points, especially
when the variance of model prediction is not suspected [140].
Number of Factors Number ofFactorial Points
Number of
Axial Points
Number of
Central Points
Total Number of
Runs
2 4 4 5 13
3 8 6 6 20
4 16 8 7 31
5 16 10 6 32
6 32 12 9 53
7 64 14 14 92
CCD has been extensively used to optimise the production of recombinant proteins (see Table 7).
5.3.2. Box Behnken Design (BBD)
BBDs are also a class of response surface designs; however, they differ from CCD in their
design structure. For example, a CCD with 4 factors requires 31 runs (experiments), whereas a
BBD only has 27 runs for the same number of factors. For 5 factors, CCD has 52 runs while BBD
has 46 runs. Reduced runs can result in significant time and cost savings in an optimisation process.
In optimisation experiments BBD is widely used as a good design to fit the quadratic model with
fewer experiments [141]. Several studies show that BBDs have contributed to production increases for
recombinant proteins (see Table 7).
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Table 7. RSM methods used to optimise the production of recombinant proteins along with their effect on yield and citing reference.
Microorganism Recombinant Protein RSM Methods Optimised Factors Optimised vs. Non-Optimised Yield Reference
E. coli BL21 Superoxide dismutase Box–Behnken design Tryptone, tween-80, lactose Enzyme activity increase by 1.54-fold [142]
E. coli BL21-SI Human interferon beta Box–Behnken Design Temperature, cell density, NaCl hIFN- β concentration increase by 5-fold [143]
E. coli BL21-SI Human interferon gamma Box–Behnken Design Temperature, biomass concentration, NaCl hIFN- γ concentration increase by 13-fold [144]
P. pastoris GS115 β-glucosidase Box-Behnken Design Sorbitol, MeOH, pH Enzyme activity increase by 3.3-fold [145]
Bacillus circulans GRS 313 Amylase Central Composite Design Soybean meal, yeast extract, wheat bran Enzyme yield increase by 1.25-fold [146]
Bacillus IMG22. α–amylase Central Composite Design Starch, yeast extract, glycerol, peptone Enzyme activity reached 17.54 IU/mL [147]
E. coli BL21(DE3), Rosetta 2
(DE3), Rosetta blue (DE3),
and Rosettagami2(DE3)
Cyclodextrin
glucanotransferase Central composite Design IPTG, arabinose B, post induction temperature Enzyme activity increase by 3.45-fold [148]
E. coli DH5α Cytochrome 2C9 protein Central Composite Design Ampicillin, chloramphenicol, IPTG, peptone Enzyme production increased by 1.05- fold [149]
E. coli BL21 (DE3) Interferon beta Central Composite Design DCW (dry cell weight), IPTG Production increase more than 3-fold [137]
E. coli BL21 (DE3) L-Asparaginase Central Composite Design Tryptone, yeast extract, peptone, CaCl2 Enzyme activity reached 17,386 U/L [150]
E. coli BL21 Peptide T-20 Central Composite Design NPK, IPTG, post induction time Production increase by more than 2-fold [106]
E. coli BL21 (DE3) TaqI endonuclease Central Composite Design Glucose, (NH4)2HPO4, KH2PO4, MgSO4.7H2O Enzyme yield increase by about 3.6-fold [151]
E. coli DH5α Xylanase Central Composite Design Glucose, (NH4)2HPO4, CK2HPO4, DKH2PO4,MgSO4
Production increase by 1.7- fold [152]
E. coli BL21 Bromelain Central Composite Design Temperature, inducer concentration, postinduction period Enzyme activity increase by 1.3-fold [153]
E. coli BL21 Phytase Central Composite Design Tryptone, yeast extract, NaCl Production increase by 2.78-fold [154]
E. coli BL21 (DE3) Chitinase Central Composite Design Temperature, incubation time Total activity increased by 1.54-fold [115]
E. coli BL21(DE3) Zinc metalloprotease Central Composite Design IPTG, Ca2+, induction time Production increase by 15-fold [22]
E. coli JM109 Carboxymethyl-Cellulose Central Composite Design Rice bran tryptone and initial pH of medium Production increase by 3-fold [155]
P. pastoris X33 Phytase Central Composite Design Yeast extract, tween-80, methanol Specific activity increase by 21.8-fold [156]
E. coli TB1 MBP-Heparinase Central Composite Design (Orthogonal) Yeast extract, glucose, Ca2+, OD600 Specific activity increase by 2.5-fold [157]
E. coli BL21 Cis-epoxysuccinate hydrolase Central Composite Design (Rotatable) Inoculation level, induction-starting time, lactose,induction temperature, induction time Enzyme activity increase by 4.6-fold [158]
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5.3.3. Summary and Choice of Optimisation Methods
Both CCD and BBD optimisation methods are widely used, the choice depends on the number
of factors and objectives of the study (see Figure 1). The standard characteristic is that all response
surface designs feature a second-order polynomial model to describe the process where interaction
terms introduce curvature into the response function and a first-order equation is inadequate to fit
the model [159,160]. CCD is the most preferred RSM [16,161] due to the fact that this design contains
full factorial or fractional factorial modes, with the potential to add central points to evaluate the
experimental error and axial points to check the variance of the model [14,140]. The number of runs
(N) in CCD is calculated using Equation (4).
N = k2 + 2k + Cp (4)
where k is the number of factors and Cp the number of centre points [162]. Table 8 is an example of a
two level CCD with two centre point replicates along with responses such as actual, predicted and
residues (see Table 8).
Table 8. Central Composite Design of four independent factors (labelled X1, X2, X3, X4 respectively)
studied at two levels (+1 and −1) including two central point replicates (0 and 0). The table also
shows different types of common responses found in optimisation process; (1) Actual data refers to
experimental results; (2) predicted data are generated by software based on the design and actual
results. The residuals are the difference between actual and predicted data.
Coded Values Responses
Runs X1 X2 X3 X4 Actual Predicted Residuals
1 −1 1 −1 1
Experimental response Predicted response data Residual data
2 −1 −1 1 1
3 0 0 0 0
4 −1 0 0 0
5 −1 1 1 −1
6 1 1 1 1
7 1 1 −1 1
8 −1 1 1 1
9 1 −1 −1 1
10 0 −1 0 0
11 1 1 1 −1
12 0 0 0 0
13 0 0 1 0
14 0 1 0 0
15 1 0 0 0
16 0 0 0 1
17 1 1 −1 −1
18 −1 1 −1 −1
19 −1 −1 1 −1
20 −1 −1 −1 1
21 1 −1 −1 −1
22 0 0 0 −1
23 1 −1 1 1
24 0 0 −1 0
25 1 −1 1 −1
26 −1 −1 −1 −1
Responses (e.g., actual, predicted and residues) data are utilised during
the optimisation analysis to evaluate the validity of the model and
determine the optimum.
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5.4. Analysis and Interpretation of Optimisation Data
Regardless of the DoE design employed, the goal is to provide a methodology for conducting
controlled experiments with the aim of identifying the vital process inputs and investigating
interactions between them [163]. At a screening level, after the experimental data are entered, the DoE
software generates a variety of graphs that are used to interpret the results obtained. These may
be scatter plots, histograms, bar charts and Pareto charts that allow the researcher to identify the
distribution of the data and statistical significance of the variables tested [85]. Different screening
analysis methods have been used in the field of protein production [77,92,112,164]. Figure 5 illustrates
a typical DoE data analysis and interpretation route from data visualisation, through experiment
validation to conclusion.
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Evaluation of Experimental Design and Predictive Model Validation
For RSM analysis, the goals are to (i) develop a predictive model that describes how the process
inputs influence the process output and (ii) determine the optimal settings of the inputs [165,166].
Following the completion of the optimisation experiments, the results are used to fit a second-order
polynomial equation (Equation (5)) [85].
Yi = β0 +∑βixi +∑βiixi2 +∑βijxixj (5)
where Yi is the predicted response, β0, βi, βii and βij are regression coefficients for the intercept,
first-order model coefficients, quadratic coefficient and linear model coefficient for the interaction
respectively [167,168]. The fit of the model is then evaluated through analysis of variance (ANOVA,
Table 9) which compares the variation due to the change in the combination of variable levels with the
variation due to the random errors [14,169].
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Table 9. An example of Analysis of Variance (ANOVA) for Response Surface Methodology fitted to a
second-order polynomial equation. The table depicts R-squared (R2), Adjusted R-squared (Adj-R2),
Predicted R-squared (Pred-R2), degree of freedom (DF), adjusted sum of square (Adj SS), adjusted
mean square (Adj MS), F-value and p-value of the model.
Source DF Adj SS Adj MS F-Value p-Value
Model 11 40.4149 3.67408 1255.77 0.0001
Linear 4 3.1531 0.78828 269.43 0.0001
Square 4 35.3209 8.83022 3018.09 0.0001
Interaction 3 1.9409 0.64697 221.13 0.0001
Residues 40 0.117 0.00293
Lack-of-fit 13 0.00369 0.00284 0.96 0.515
Pure error 27 0.0802 0.00297
Total 51 40.532
R2= 99.71%, Adj-R2 = 99.63%, Pred-R2 = 99.48%
The coefficient value of R2 defines how well the model fits the data. The closer the R2 is to 1,
the better it describes the experimental data [21]. The Adjusted R2 is used to check the adequacy of the
model by measuring the amount of variation about the mean derived from the model; the closer the
value is to 1, the better it describes the model [130]. For example, in Table 9, the R2 = 0.9971 indicates the
significance of regression of the fitting equation and therefore, adequacy of discrimination, indicating
that only 0.29% of the total variation could not be explained by the fitting equation [142]. When
R2 = 99.71%, Adj-R2 = 99.63%, Pred-R2 = 99.48% are in good agreement with each other (as in Table 9),
this provides confidence in the accuracy of the model [156].
Additionally, the p-value and signal-to-noise ratio are used to estimate the quality of the model.
For a significant model, a p-value < 0.05 is desirable [170]. Appropriate precision measures the
signal-to-noise ratio; where a ratio greater than 4 indicates an adequate model [171] and is commonly
used in protein production optimisation [172,173]. Furthermore, the p-value lack of fit and the plot of
observed values versus predicted values are used to estimate the quality of the model. With a good
model, the p-value lack of fit should be >0.05 [168] as shown in Table 9. Finally, all data should fall on
the straight line on the observed versus predicted plots [145] as shown in Figure 6.
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Figure 6. A linear plot estimating accuracy of a regression model by comparing actual versus predicted
data sets. The plot determines he correlation betwe n the model’s predictions and actual data and
th reby in ic tes how wel the model fit data. The closer the value of R2 is to 1, the better the fit of
the line to the data and the g odness of the model.
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5.5. Optimum Determination
Once the predictive model has been validated, it can be used to determine the optimised
parameters. The statistical tools embedded in DoE software are used to generate 3D-graphs, called
surface contour plots that visually describe the relationship between variables and response [174,175].
The 3-D surface and contour graphs are generated as a combination of two test variables with the
others maintained at their respective zero levels [176] see Figure 7. Surface, contour and residual plots,
along with ANOVA, are the main optimisation analysis tools commonly used to determine optimum
levels for high yields of recombinant protein [20,177–179].
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Figure 7. An example of response surface and contour plot adapted from Nelofer et al., 2012 [163].
The figure depicts the two-factor interaction (in this case the two factors explored are glucose and
culturing temperature) here one factor influences the response of another factor. It also shows the
visualisation of optimum levels. The colour scale indicates the level of lipase activity (IU/mL) here
red indicates the region of optimal yield, yellow indicates medium yield, and green indicates low yield.
In this case, the optimal enzyme activity (33 IU/mL) was achieved at a culture temperature between
30 ◦C a d 34 ◦C; and a glucose co centration between 40 g/mL–50 g/mL. Image used with permission.
6. Conclusions; Getting It ‘Just Right’
DoE offers many choices for screening and optimisation designs which advance traditional
optimisation methodologies, such as one-factor-at-a-time. The statistical approach offered by DoE
has pr ven to be applicable in protein biotech ol gy effectively investigating media composition
and culture condition factors in recombinant protein production. DoE’s ability to identify the m st
influential factors in recombinant protein expression through screening designs and identify the
factor/levels that give the maximum yield has considerably enhanced the pr duction of soluble,
activ recombinant protein. With the rece t development of more fl xible scr eni g optimisation
designs and enhancements in computational processing DoE will continue to find applications in
biotechnology; in recombinant prot in production and beyond.
Author Contributions: All authors contributed substantially to this body of work, in the form of;
Conceptualization, A.U., G.K.K., G.T.H. and B.J.R.; Data Curation, A.U.; Writing-Original Draft Preparation, A.U.,
G.K.K., G.T.H. and B.J.R.; Writing-Review & Editing, A.U., G.K.K., G.T.H. and B.J.R.; Supervision, G.K.K., G.T.H.
and B.J.R.; Project Administration, B.J.R.; Funding Acquisition, B.J.R., G.T.H. and A.U.
Bioengineering 2018, 5, 89 18 of 27
Funding: This research was funded by the Dublin Institute of Technology Fiosraigh Postgraduate Scheme [AU].
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Adrio, J.L.; Demain, A.L. Recombinant organisms for production of industrial products. Bioeng. Bugs 2010, 1,
116–131. [CrossRef] [PubMed]
2. Mitragotri, S.; Burke, P.A.; Langer, R. Overcoming the challenges in administering biopharmaceuticals:
Formulation and delivery strategies. Nat. Rev. Drug Discov. 2014, 13, 655–672. [CrossRef] [PubMed]
3. Manning, M.C.; Chou, D.K.; Murphy, B.M.; Payne, R.W.; Katayama, D.S. Stability of protein pharmaceuticals:
An update. Pharm. Res. 2010, 27, 544–575. [CrossRef] [PubMed]
4. Ferrer-miralles, N.; Villaverde, A. Bacterial Cell Factories for Recombinant Protein Production; expanding
the catalogue. Microb. Cell Fac. 2013, 12, 133. [CrossRef] [PubMed]
5. Papaneophytou, C.; Kontopidis, G.A. Optimization of TNF-α overexpression in Escherichia coli using response
surface methodology: Purification of the protein and oligomerization studies. Protein Expr. Purif. 2012, 86,
35–44. [CrossRef] [PubMed]
6. Marini, G.; Luchese, M.D.; Argondizzo, A.P.C.; de Góes, A.M.; Galler, R.; Alves, T.L.M. Experimental design
approach in recombinant protein expression: Determining medium composition and induction conditions for
expression of pneumolysin from Streptococcus pneumoniae in Escherichia coli and preliminary purification
process. BMC Biotechnol. 2014, 14, 1. [CrossRef] [PubMed]
7. Rosano, G.L.; Ceccarelli, E.A. Recombinant protein expression in Escherichia coli: Advances and challenges.
Front. Microbiol. 2014, 5, 1–17. [CrossRef] [PubMed]
8. Fakruddin, M.; Mohammad Mazumdar, R.; Bin Mannan, K.S.; Chowdhury, A.; Hossain, M.N. Critical Factors
Affecting the Success of Cloning, Expression, and Mass Production of Enzymes by Recombinant E. coli. ISRN
Biotechnol. 2013, 3, 1–7. [CrossRef] [PubMed]
9. Lambertz, C.; Garvey, M.; Klinger, J.; Heesel, D.; Klose, H.; Fischer, R. Challenges and advances in the
heterologous expression of cellulolytic enzymes: A review. Biotechnol. Biofuels 2014, 7, 1–15. [CrossRef]
[PubMed]
10. Choi, J.H.; Keum, K.C.; Lee, S.Y. Production of recombinant proteins by high cell density culture of
Escherichia coli. Chem. Eng. Sci. 2006, 61, 876–885. [CrossRef]
11. Berlec, A.; Štrukelj, B. Current state and recent advances in biopharmaceutical production in Escherichia coli,
yeasts and mammalian cells. J. Ind. Microbiol. Biotechnol. 2013, 40, 257–274. [CrossRef] [PubMed]
12. Yang, Z.; Zhang, L.; Zhang, Y.; Zhang, T.; Feng, Y.; Lu, X. Highly efficient production of soluble proteins
from insoluble inclusion bodies by a Two-Step-Denaturing and refolding method. PLoS ONE 2011, 6, 1–9.
[CrossRef] [PubMed]
13. Sørensen, H.P.; Mortensen, K.K. Soluble expression of recombinant proteins in the cytoplasm of Escherichia coli.
Microb. Cell Fact. 2005, 8, 1–8. [CrossRef] [PubMed]
14. Papaneophytou, C.P.; Kontopidis, G. Statistical approaches to maximize recombinant protein expression in
Escherichia coli: A general review. Protein Expr. Purif. 2014, 94, 22–32. [CrossRef] [PubMed]
15. Makino, T.; Skretas, G.; Georgiou, G. Strain engineering for improved expression of recombinant proteins in
bacteria. Microb. Cell. Fact. 2011, 10, 32. [CrossRef] [PubMed]
16. Jiang, S.; Liu, M.; Wang, B.; Jiang, K.; Wang, L. Statistical optimization of medium composition and
culture condition for the production of recombinant anti-lipopolysaccharide factor of Eriocheir sinensis in
Escherichia coli. Chin. J. Oceanol. Limnol. 2011, 29, 1249–1259. [CrossRef]
17. Xu, Y.; Li, Y.; Xu, S.; Liu, Y.; Wang, X.; Tang, J. Improvement of xylanase production by Aspergillus niger XY-1
using response surface methodology for optimizing the medium composition. J. Zhejiang Univ. Sci. B 2008, 9,
558–566. [CrossRef] [PubMed]
18. Shafiee, F.; Rabbani, M.; Jahanian-Najafabadi, A. Optimization of the Expression of DT386-BR2 Fusion
Protein in Escherichia coli using Response Surface Methodology. Adv. Biomed. Res. 2017, 6, 22. [CrossRef]
[PubMed]
19. Akbarzadeh, A.; Dehnavi, E.; Aghaeepoor, M.; Amani, J. Optimization of recombinant expression of synthetic
bacterial phytase in Pichia pastoris using response surface methodology. Jundishapur J. Microbiol. 2015, 8,
e27553. [CrossRef] [PubMed]
Bioengineering 2018, 5, 89 19 of 27
20. Maharjan, S.; Singh, B.; Bok, J.D.; Kim, J.I.; Jiang, T.; Cho, C.S. Exploring codon optimization and response
surface methodology to express biologically active transmembrane RANKL in E. Coli. PLoS ONE 2014, 9,
e96259. [CrossRef] [PubMed]
21. Larentis, A.L.; Nicolau, J.F.M.Q.; Esteves, G.D.S.; Vareschini, D.T.; de Almeida, F.V.R.; dos Reis, M.G.
Evaluation of pre-induction temperature, cell growth at induction and IPTG concentration on the expression
of a leptospiral protein in E. coli using shaking flasks and microbioreactor. BMC Res. Notes 2014, 7, 671.
[CrossRef] [PubMed]
22. Beigi, L.; Karbalaei-Heidari, H.R.; Kharrati-Kopaei, M. Optimization of an extracellular zinc-metalloprotease
(SVP2) expression in Escherichia coli BL21 (DE3) using response surface methodology. Protein Expr. Purif.
2012, 84, 161–166. [CrossRef] [PubMed]
23. Chen, Q.; Ruan, H.; Zhang, H.; Ni, H.; He, G. Enhanced production of elastase by Bacillus licheniformis
ZJUEL31410: Optimization of cultivation conditions using response surface methodology. J. Zhejiang Univ.
Sci. B 2007, 8, 845–852. [CrossRef] [PubMed]
24. Zhou, W.W.; He, Y.L.; Niu, T.G.; Zhong, J.J. Optimization of fermentation conditions for production of
anti-TMV extracellular ribonuclease by Bacillus cereus using response surface methodology. Bioprocess Biosyst.
Eng. 2010, 33, 657–663. [CrossRef] [PubMed]
25. Zhou, Y.; Sun, Y.B.; He, H.W.; Feng, J.T.; Zhang, X.; Han, L.R. Optimization of medium compositions to
improve a novel glycoprotein production by Streptomyces kanasenisi ZX01. AMB Express 2017, 7, 6. [CrossRef]
[PubMed]
26. Altekar, M.; Homon, C.A.; Kashem, M.; Mason, S.W.; Nelson, R.M.; Patnaude, L.A. Assay Optimization:
A Statistical Design of Experiments Approach. Clin. Lab. Med. 2007, 27, 139–154. [CrossRef] [PubMed]
27. Samaei-Nouroozi, A.; Rezaei, S.; Khoshnevis, N.; Doosti, M.; Hajihoseini, R.; Khoshayand, M.R.
Medium-based optimization of an organic solvent-tolerant extracellular lipase from the isolated halophilic
Alkalibacillus Salilacus. Extremophiles 2015, 19, 933–947. [CrossRef] [PubMed]
28. Gangadharan, D.; Sivaramakrishnan, S.; Nampoothiri, K.M.; Sukumaran, R.K.; Pandey, A. Response surface
methodology for the optimization of alpha amylase production by Bacillus Amyloliquefaciens. Bioresour.
Technol. 2008, 99, 4597–4602. [CrossRef] [PubMed]
29. Setiawan, D.; Fadhlillah, M.; Pertiwi, W.; Gaffar, S.; Subroto, T. Optimization of The Expression of
Recombinant Universal Infleunza vaccine Candidate in Escherichia coli Using Response Surface Methodology.
IOSR J. Pharm. 2018, 8, 53–60.
30. Demain, A.L.; Vaishnav, P. Production of Recombinant Proteins by Microbes and Higher Organisms.
Biotechnol. Adv. 2009, 27, 297–306. [CrossRef] [PubMed]
31. Kim, Y.; Babnigg, G.; Jedrzejczak, R.; Eschenfeldt, W.H.; Li, H.; Maltseva, N. High-throughput protein
purification and quality assessment for crystallization. Methods 2011, 55, 12–28. [CrossRef] [PubMed]
32. Mondal, S.; Shet, D. High yield expression of proteins in E. coli for NMR studies. Adv. Biosci. 2013, 4, 751–767.
[CrossRef]
33. Li, S.; Yang, X.; Yang, S.; Zhu, M.; Wang, X. Technology Prospecting on Enzymes: Application, Marketing
and Engineering Abstract: Enzymes are protein molecules functioning as specialized catalysts for chemical
reactions. They have contributed greatly to the traditional and modern chemical industr. Comput. Struct.
Biotechnol. J. 2012, 2, e201209017. [CrossRef] [PubMed]
34. Dubey, A.A.; Singh, M.I.; Jain, V. Rapid and Robust PCR-Based All-Recombinant Cloning Methodology.
PLoS ONE 2016, 11, 1–11. [CrossRef] [PubMed]
35. Barnes, H.; Arlotto, M.P.; Waterman, M.R. Expression and enzymatic activity of recombinant cytochrome
P450 17 alpha-hydroxylase in Escherichia coli. Proc. Natl. Acad. Sci. USA 1991, 88, 5597–5601. [CrossRef]
[PubMed]
36. Han, M.; Yu, X. Enhanced expression of heterologous proteins in yeast cells via the modification of
N-glycosylation sites. Bioengineered 2015, 6, 115–118. [CrossRef] [PubMed]
37. Araki, Y.; Hamafuji, T.; Noguchi, C.; Shimizu, N. Efficient recombinant production in mammalian cells using
a novel IR/MAR gene amplification method. PLoS ONE 2012, 7, 1–10. [CrossRef] [PubMed]
38. Durocher, Y. High-level and high-throughput recombinant protein production by transient transfection of
suspension-growing human 293-EBNA1 cells. Nucleic Acids Res. 2002, 30, 1–11. [CrossRef]
Bioengineering 2018, 5, 89 20 of 27
39. Zimran, A.; Brill-almon, E.; Chertkoff, R.; Petakov, M.; Blanco-favela, F.; Muñoz, T.; Solorio-Meza, S.E.;
Amato, D.; Duran, G.; Giona, F.; et al. Pivotal trial with plant cell-expressed recombinant glucocerebrosidase,
taliglucerase alfa, a novel enzyme replacement therapy for Gaucher disease. Blood 2011, 118, 5767–5773.
[CrossRef] [PubMed]
40. Bleckmann, M.; Schmelz, S.; Schinkowski, C.; Scrima, A.; van den Heuvel, J. Fast plasmid based protein
expression analysis in insect cells using an automated SplitGFP screen. Biotechnol. Bioeng. 2016, 113,
1975–1983. [CrossRef] [PubMed]
41. Khow, O.; Suntrarachun, S. Strategies for production of active eukaryotic proteins in bacterial expression
system. Asian Pac. J. Trop. Biomed. 2012, 2, 159–162. [CrossRef]
42. Tanimura, K.; Takashima, S.; Matsumoto, T.; Tanaka, T.; Kondo, A. 2,3-Butanediol production from cellobiose
using exogenous beta-glucosidase-expressing Bacillus Subtilis. Appl. Microbiol. Biotechnol. 2016, 100,
5781–5789. [CrossRef] [PubMed]
43. Fontani, S.; Niccolai, A.; Kapat, A.; Olivieri, R. Studies on the maximization of recombinant Helicobacter
pylori neutrophil-activating protein production in Escherichia coli: Application of Taguchi robust design and
response surface methodology for process optimization. World J. Microbiol. Biotechnol. 2003, 19, 711–717.
[CrossRef]
44. Adrio, J.L.; Demain, A.L. Microbial enzymes: Tools for biotechnological processes. Biomolecules 2014, 4,
117–139. [CrossRef] [PubMed]
45. Gopal, G.J.; Kumar, A. Strategies for the production of recombinant protein in Escherichia coli. Protein J. 2013,
32, 419–425. [CrossRef] [PubMed]
46. Gurung, P.; Lukens, J.R.; Kanneganti, T. Overview of the puification of recombinant proteins. HHS Public
Access 2016, 3, 193–201.
47. El-Helow, E.R.; Abdel-Fattah, Y.R.; Ghanem, K.M.; Mohamad, E. Application of the response surface
methodology for optimizing the activity of an aprE-driven gene expression system in Bacillus Subtilis. Appl.
Microbiol. Biotechnol. 2000, 54, 515–520. [CrossRef] [PubMed]
48. Li, R.F.; Wang, B.; Liu, S.; Chen, S.H.; Yu, G.H.; Yang, S.Y. Optimization of the Expression Conditions of
CGA-N46 in Bacillus subtilis DB1342(p-3N46) by Response Surface Methodology. Interdiscip. Sci. Comput. Life
Sci. 2016, 8, 277–283. [CrossRef] [PubMed]
49. Mohammadi, H.S.; Mostafavi, S.S.; Soleimanib, S.; Bozorgian, S.; Pooraskari, M.; Kianmehr, A. Response
surface methodology to optimize partition and purification of two recombinant oxidoreductase enzymes,
glucose dehydrogenase and D-galactose dehydrogenase in aqueous two-phase systems. Protein Expr. Purif.
2015, 108, 41–47. [CrossRef] [PubMed]
50. Murashima, K.; Chen, C.; Kosugi, A.; Tamaru, Y.; Doi, R.H.; Wong, S. Heterologous Production of Clostridium
cellulovorans engB, Using Protease-Deficient Bacillus subtilis, and Preparation of Active Recombinant
Cellulosomes. J. Bacteriol. 2002, 184, 76–81. [CrossRef] [PubMed]
51. Berrow, N.S.; Büssow, K.; Coutard, B.; Diprose, J.; Ekberg, M.; Folkers, G.E. Recombinant protein expression
and solubility screening in Escherichia coli: A comparative study. Acta Crystallogr. Sect. D Biol. Crystallogr.
2006, 62, 1218–1226. [CrossRef] [PubMed]
52. de Marco, A. Strategies for successful recombinant expression of disulfide bond-dependent proteins in
Escherichia coli. Microb. Cell Fact. 2009, 8, 1–26. [CrossRef] [PubMed]
53. Oliveira, C.; Guimarães, P.M.R.; Domingues, L. Recombinant microbial systems for improved β-galactosidase
production and biotechnological applications. Biotechnol. Adv. 2011, 29, 600–609. [CrossRef] [PubMed]
54. Peti, W.; Page, R. Strategies to maximize heterologous protein expression in Escherichia coli with minimal
cost. Protein Expr. Purif. 2007, 51, 1–10. [CrossRef] [PubMed]
55. Baweja, M.; Nain, L.; Kawarabayasi, Y.; Shukla, P. Current technological improvements in enzymes toward
their biotechnological applications. Front. Microbiol. 2016, 7, 1–13. [CrossRef] [PubMed]
56. Jarmander, J.; Janoschek, L.; Lundh, S.; Larsson, G.; Gustavsson, M. Process optimization for increased
yield of surface-expressed protein in Escherichia coli. Bioprocess Biosyst. Eng. 2014, 37, 1685–1693. [CrossRef]
[PubMed]
57. Mahalik, S.; Sharma, A.K.; Mukherjee, K.J. Genome engineering for improved recombinant protein expression
in Escherichia coli. Microb. Cell Fact. 2014, 13, 177. [CrossRef] [PubMed]
Bioengineering 2018, 5, 89 21 of 27
58. Zhang, L.; Fu, Q.; Li, W.; Wang, B.; Yin, X.; Liu, S. Identification and characterization of a novel β-glucosidase
via metagenomic analysis of Bursaphelenchus xylophilus and its microbial flora. Sci. Rep. 2017, 7, 1–11.
[CrossRef] [PubMed]
59. Jana, S.; Deb, J.K. Strategies for efficient production of heterologous proteins in Escherichia coli. Appl. Microbiol.
Biotechnol. 2005, 67, 289–298. [CrossRef] [PubMed]
60. Khan, S.; Pozzo, T.; Megyeri, M.; Lindahl, S.; Sundin, A.; Turner, C. Aglycone specificity of Thermotoga
neapolitana β-glucosidase 1A modified by mutagenesis, leading to increased catalytic efficiency in
quercetin-3-glucoside hydrolysis. BMC Biochem. 2011, 12, 1–11. [CrossRef] [PubMed]
61. Khushoo, A.; Pal, Y.; Singh, B.N.; Mukherjee, K.J. Extracellular expression and single step purification of
recombinant Escherichia coli l-asparaginase II. Protein Expr. Purif. 2004, 38, 29–36. [CrossRef] [PubMed]
62. Volontè, F.; Marinelli, F.; Gastaldo, L.; Sacchi, S.; Pilone, M.S.; Pollegioni, L. Optimization of
glutaryl-7-aminocephalosporanic acid acylase expression in E. Coli. Protein Expr. Purif. 2008, 61, 131–137.
[CrossRef] [PubMed]
63. Zelena, K.; Eisele, N.; Berger, R.G. Escherichia coli as a production host for novel enzymes from basidiomycota.
Biotechnol. Adv. 2014, 32, 1382–1395. [CrossRef] [PubMed]
64. Costa, S.; Almeida, A.; Castro, A.; Domingues, L. Fusion tags for protein solubility, purification, and
immunogenicity in Escherichia coli: The novel Fh8 system. Front. Microbiol. 2014, 5, 1–20. [CrossRef]
[PubMed]
65. Dickson, J.M.J.; Lee, W.; Shepherd, P.R.; Buchanan, C.M. Enzyme activity effects of N-terminal His-tag
attached to catalytic sub-unit of phosphoinositide-3-kinase. Biosci. Rep. 2013, 33, 857–863. [CrossRef]
[PubMed]
66. Zhang, H.; Fu, G.; Zhang, D. Cloning, Characterization, and production of a novel lysozyme by different
expression hosts. J. Microbiol. Biotechnol. 2014, 24, 1405–1412. [CrossRef] [PubMed]
67. Deng, Y.; Nie, Y.; Zhang, Y.; Wang, Y.; Xu, Y. Improved inducible expression of Bacillus naganoensis
pullulanase from recombinant Bacillus subtilis by enhancer regulation. Protein Expr. Purif. 2018, 148, 9–15.
[CrossRef] [PubMed]
68. Song, Y.; Nikoloff, J.M.; Zhang, D. Improving protein production on the level of regulation of both expression
and secretion pathways in Bacillus Subtilis. J. Microbiol. Biotechnol. 2015, 25, 963–977. [CrossRef] [PubMed]
69. Song, W.; Nie, Y.; Mu, X.Q.; Xu, Y. Enhancement of extracellular expression of Bacillus naganoensis
pullulanase from recombinant Bacillus subtilis: Effects of promoter and host. Protein Expr. Purif. 2016,
124, 23–31. [CrossRef] [PubMed]
70. Thuy, L.A.T.; Schumann, W. A novel cold-inducible expression system for Bacillus Subtilis. Protein Expr. Purif.
2007, 53, 264–269. [CrossRef] [PubMed]
71. Gomes, L.C.; Mergulh, F.J. Effects of antibiotic concentration and nutrient medium composition on
Escherichia coli biofilm formation and green fluorescent protein expression. FEMS Microbiol. Lett. 2018,
364, 1–8. [CrossRef] [PubMed]
72. Jia, B.; Jeon, C.O. High-throughput recombinant protein expression in Escherichia coli: Current status and
future perspectives. Open Biol. 2016, 6, 1–17. [CrossRef] [PubMed]
73. Chhetri, G.; Kalita, P.; Tripathi, T. An efficient protocol to enhance recombinant protein expression using
ethanol in Escherichia coli. MethodsX 2015, 2, 385–391. [CrossRef] [PubMed]
74. Ryan, B.J.; O’Fágáin, C. Effects of single mutations on the stability of horseradish peroxidase to hydrogen
peroxide. Biochimie 2007, 89, 1029–1032. [CrossRef] [PubMed]
75. Deller, M.C.; Kong, L.; Rupp, B. Protein stability: A crystallographer’s perspective. Acta Crystallogr. Sect.
Struct. Biol. Commun. 2016, 72, 72–95. [CrossRef] [PubMed]
76. Vincentelli, R.; Cimino, A.; Geerlof, A.; Kubo, A.; Satou, Y.; Cambillau, C. High-throughput protein expression
screening and purification in Escherichia coli. Methods 2011, 55, 65–72. [CrossRef] [PubMed]
77. Lee, K.M.; Rhee, C.H.; Kang, C.K.; Kim, J.H. Sequential and Simultaneous Statistical Optimization by
Dynamic Design of Experiment for Peptide Overexpression in Recombinant Escherichia coli. Appl. Biochem.
Biotechnol. 2006, 135, 59–80. [CrossRef]
78. Lebendiker, M.; Danieli, T. Production of prone-to-aggregate proteins. FEBS Lett. 2014, 588, 236–246.
[CrossRef] [PubMed]
Bioengineering 2018, 5, 89 22 of 27
79. Malik, A.; Alsenaidy, A.M.; Elrobh, M.; Khan, W.; Alanazi, M.S.; Bazzi, M.D. Optimization of expression
and purification of HSPA6 protein from Camelus dromedarius in E. coli. Saudi J. Biol. Sci. 2016, 23, 410–419.
[CrossRef] [PubMed]
80. Ou, J.; Wang, L.; Ding, X.; Du, J.; Zhang, Y.; Chen, H. Stationary phase protein overproduction is a
fundamental capability of Escherichia coli. Biochem. Biophys. Res. Commun. 2004, 314, 174–180. [CrossRef]
[PubMed]
81. Papaneophytou, C.P.; Rinotas, V.; Douni, E.; Kontopidis, G. A statistical approach for optimization of RANKL
overexpression in Escherichia coli: Purification and characterization of the protein. Protein Expr. Purif. 2013,
90, 9–19. [CrossRef] [PubMed]
82. Mandenius, C.; Brundin, A. Review: Biocatalysts and Bioreactor Design Optimization, Bioprocess
Methodology, Using Design-of-experiments. Biotechnol. Progr. 2008, 24, 1191–1203. [CrossRef] [PubMed]
83. Hajihassan, Z.; Biroonro, N. Enhanced expression of recombinant activin a in Escherichia coli by optimization
of induction parameters. J. Sci. Islam Repub. Iran 2018, 29, 105–111.
84. Batumalaie, K.; Khalili, E.; Mahat, N.A.; Huyop, F.Z.; Wahab, R.A. A statistical approach for optimizing
the protocol for overexpressing lipase KV1 in Escherichia coli: Purification and characterization. Biotechnol.
Biotechnol. Equip. 2018, 32, 69–87.
85. Prabhu, A.A.; Mandal, B.; Dasu, V.V. Medium optimization for high yield production of extracellular human
interferon-γ from Pichia pastoris: A statistical optimization and neural network-based approach. Korean J.
Chem. Eng. 2017, 34, 1109–1121. [CrossRef]
86. Aghaeepoor, M.; Kobarfard, F.; Akbari Eidgahi, M.R.; Shabani, A.; Dehnavi, E.; Ahmadi, M. Optimization
of culture media for extracellular expression of streptokinase in Escherichia coli using response surface
methodology in combination with plackett-burman design. Trop. J. Pharm. Res. 2017, 16, 2567–2576.
[CrossRef]
87. Puri, M.; Kaur, A.; Singh, R.S.; Singh, A. Response surface optimization of medium components for
naringinase production from staphylococcus xylosus MAK2. Appl. Biochem. Biotechnol. 2010, 162, 181–191.
[CrossRef] [PubMed]
88. Pandey, R.K.; Senthil, P.; Boriwal, L.; Malviya, A. Experimental investigation on influence of ECM process
parameters on responses using full factorial design. Mater. Today Proc. 2017, 4, 3666–3671. [CrossRef]
89. Nam, S.H.; Park, J.; Jun, W.; Kim, D.; Ko, J.A.; Abd El-Aty, A.M. Transglycosylation of gallic acid by using
Leuconostoc glucansucrase and its characterization as a functional cosmetic agent. AMB Express 2017, 7, 224.
[CrossRef] [PubMed]
90. Wahid, Z.; Nadir, N. Improvement of one factor at a time through design of experiments. World Appl. Sci. J.
2013, 21, 56–61.
91. Anbu, P.; Annadurai, G.; Hur, B. Production of alkaline protease from a newly isolated
Exiguobacterium profundum BK-P23 evaluated using the response surface methodology. Biologia 2013, 68,
186–193. [CrossRef]
92. Roohi, M.K. Statistical optimization of cold-active chitinase production by mutagenized cells of multi-enzyme
producing Bacillus cereus GA6. Rend Lincei. 2015, 26, 271–280. [CrossRef]
93. Mahajan, P.M.; Gokhale, S.V.; Lele, S.S. Production of Nattokinase Using Bacillus natto NRRL 3666: Media
optimization, scale Up, and kinetic modeling. Food Sci. Biotechnol. 2010, 9, 1593–1603. [CrossRef]
94. Purama, R.K.; Goyal, A. Application of response surface methodology for maximizing dextransucrase
production from leuconostoc mesenteroides NRRL B-640 in a bioreactor. Appl. Biochem. Biotechnol. 2008, 151,
182–192. [CrossRef] [PubMed]
95. Haider, M.A.; Pakshirajan, K. Screening and optimization of media constituents for enhancing lipolytic
activity by a soil microorganism using statistically designed experiments. Appl. Biochem. Biotechnol. 2007,
141, 377–390. [CrossRef] [PubMed]
96. Samarin, Z.E.; Abolghasemi, S.; Dehnavi, E.; Akbarzadeh, A.; Hadian, A.; Khodabandeh, M. Response
Surface Optimization of the Expression Conditions for Synthetic Human Interferon α -2b Gene in
Escherichia coli. Indian J. Pharm. Sci. 2018, 80, 470–479. [CrossRef]
97. Saravanan, P.; Muthuvelayudham, R.; Rajesh Kannan, R.; Viruthagiri, T. Optimization of cellulase production
using Trichoderma reesei by RSM and comparison with genetic algorithm. Front. Chem. Sci. Eng. 2012, 6,
443–452. [CrossRef]
Bioengineering 2018, 5, 89 23 of 27
98. Graslund, S.; Nordlund, P.; Weigelt, J.; Hallberg, B.M.; Bray, J.; Gileadi, O.; Knapp, S. Protein production and
purification. Nat. Methods 2008, 5, 135–146. [CrossRef] [PubMed]
99. Naili, B.; Sahnoun, M.; Bejar, S.; Kammoun, R. Optimization of submerged Aspergillus oryzae S2 α-amylase
production. Food Sci. Biotechnol. 2016, 25, 185–192. [CrossRef] [PubMed]
100. Goswami, R.; Mukherjee, S.; Chakraborty, A.K.; Balachandran, S.; Sinha Babu, S.P.; Chaudhury, S.
Optimization of growth determinants of a potent cellulolytic bacterium isolated from lignocellulosic biomass
for enhancing biogas production. Clean Technol. Environ. Policy 2016, 18, 1565–1583. [CrossRef]
101. Zhao, Y.; Liang, Y.; Liu, L.; Cheng, J.; Yuan, Y. Medium Optimization for Antifungal Active Substance
Production from Streptomyces Lydicus Using Response Surface Methodology. Trans. Tianjin Univ. 2017, 23,
78–86. [CrossRef]
102. Manivasagan, P.; Sivasankar, P.; Venkatesan, J.; Sivakumar, K.; Kim, S.K. Optimization, production and
characterization of glycolipid biosurfactant from the marine actinobacterium, Streptomyces sp. MAB36.
Bioprocess Biosyst. Eng. 2014, 37, 783–797. [CrossRef] [PubMed]
103. Ramadas, N.V.; Soccol, C.R.; Pandey, A. A statistical approach for optimization of polyhydroxybutyrate
production by Bacillus sphaericus NCIM 5149 under submerged fermentation using central composite design.
Appl. Biochem. Biotechnol. 2010, 162, 996–1007. [CrossRef] [PubMed]
104. Kandasamy, S.; Muthusamy, G.; Balakrishnan, S.; Duraisamy, S.; Thangasamy, S.; Seralathan, K.K.
Optimization of protease production from surface-modified coffee pulp waste and corncobs using Bacillus sp.
by SSF. 3 Biotech 2016, 6, 1–11. [CrossRef] [PubMed]
105. Jones, B.; Nachtsheim, C.J. A Class of Three-Level Designs for Definitive Screening in the Presence of
Second-Order Effects. J. Qual. Technol. 2011, 43, 1–15. [CrossRef]
106. Lee, C.W.; Wang, H.J.; Hwang, J.K.; Tseng, C.P. Protein thermal stability enhancement by designing salt
bridges: A combined computational and experimental study. PLoS ONE 2014, 9, e112751. [CrossRef]
[PubMed]
107. Mittal, D.; Srivatsava, A.; Govindasamy, S.; Chandrasekaran, M. Optimization of Critical Medium
Components for Protein Production by Nostoc ellipsosporum Using Response Surface Methodology. Arab. J.
Sci. Eng. 2015, 40, 875–880. [CrossRef]
108. Adinarayana, K.; Ellaiah, P. Response surface optimization of the critical medium components for the
production of alkaline protease by a newly isolated Bacillus Sp.. J. Pharm. Pharm. Sci. 2002, 5, 272–278.
[PubMed]
109. Bhagwat, P.K.; Jhample, S.B.; Dandge, P.B. Statistical medium optimization for the production of
collagenolytic protease by Pseudomonas sp. SUK using response surface methodology. Microbiology 2015, 84,
520–530. [CrossRef]
110. Chandel, M.; Azmi, W. Bioresource Technology Optimization of process parameters for the production of
tyrosine phenol lyase by Citrobacter freundii MTCC 2424. Bioresour. Technol. 2009, 100, 1840–1846. [CrossRef]
[PubMed]
111. Gao, H.; Liu, M.; Liu, J.; Dai, H.; Zhou, X.; Liu, X. Medium optimization for the production of avermectin
B1a by Streptomyces avermitilis 14-12A using response surface methodology. Bioresour. Technol. 2009, 100,
4012–4016. [CrossRef] [PubMed]
112. El-Ahmady El-Naggar, N.; Moawad, H.; Abdelwahed, N.A.M. Optimization of fermentation conditions
for enhancing extracellular production of L-asparaginase, an anti-leukemic agent, by newly isolated
Streptomyces brollosae NEAE-115 using solid state fermentation. Ann. Microbiol. 2017, 67, 1–15. [CrossRef]
113. Wass, J. First Steps in Experimental Design–The Screening Experiment. J. Valid. Technol. 2010, 49–57.
114. Pham, P.; Taillandier, P.; Delmas, M.; Strehaiano, P. Optimization of a culture medium for xylanase production
by Bacillus sp. using statistical experimental designs. World J. Microbiol. Biotechnol. 1998, 14, 185–190.
[CrossRef]
115. Vijayaraghavan, P.; Vincent, S.G.P. Statistical optimization of fibrinolytic enzyme production by
Pseudoalteromonas sp. IND11 using cow dung substrate by response surface methodology. Springerplus
2014, 3, 60. [CrossRef] [PubMed]
116. Liu, C.L.; Lin, T.H.; Juang, R.S. Optimization of recombinant hexaoligochitin-producing chitinase production
with response surface methodology. Int. J. Biol. Macromol. 2013, 62, 518–522. [CrossRef] [PubMed]
Bioengineering 2018, 5, 89 24 of 27
117. Zhu, C.H.; Lu, F.P.; He, Y.N.; Zhang, J.K.; Du, L.X. Statistical optimization of medium components for
avilamycin production by Streptomyces viridochromogenes Tü57-1 using response surface methodology. J. Ind.
Microbiol. Biotechnol. 2007, 34, 271–278. [CrossRef] [PubMed]
118. Jia, B.; Jin, Z.H.; Mei, L.H. Medium optimization based on statistical methodologies for pristinamycins
production by Streptomyces Pristinaespiralis. Appl. Biochem. Biotechnol. 2008, 144, 133–143. [CrossRef]
[PubMed]
119. Kammoun, R.; Naili, B.; Bejar, S. Application of a statistical design to the optimization of parameters and
culture medium for α-amylase production by Aspergillus oryzae CBS 819.72 grown on gruel (wheat grinding
by-product). Bioresour. Technol. 2008, 99, 5602–5609. [CrossRef] [PubMed]
120. Niladevi, K.N.; Sukumaran, R.K.; Jacob, N.; Anisha, G.S.; Prema, P. Optimization of laccase production
from a novel strain-Streptomyces psammoticus using response surface methodology. Microbiol. Res. 2009, 164,
105–113. [CrossRef] [PubMed]
121. Sai-Ut, S.; Benjakul, S.; Sumpavapol, P.; Kishimura, H. Optimization of gelatinolytic enzyme production by
B. amyloliquefaciens sp. H11 through Plackett-Burman design and response surface methodology. Int. Aquat.
Res. 2014, 6, 59. [CrossRef]
122. Thenmozhi, C.; Sankar, R.; Karuppiah, V.; Sampathkumar, P. L-asparaginase production by mangrove
derived Bacillus cereus MAB5: Optimization by response surface methodology. Asian Pac. J. Trop. Med. 2011,
4, 486–491. [CrossRef]
123. Jones, B.; Nachtsheim, C.J. Definitive screening designs with added two-level categorical factors. J. Qual.
Technol. 2013, 45, 121–129. [CrossRef]
124. Swalley, S.E.; Fulghum, J.R.; Chambers, S.P. Screening factors effecting a response in soluble protein
expression: Formalized approach using design of experiments. Anal. Biochem. 2006, 351, 122–127. [CrossRef]
[PubMed]
125. Cao, W.; Li, H.; Zhang, J.; Li, D.; Acheampong, D.O.; Chen, Z. Periplasmic expression optimization of
VEGFR2 D3 adopting response surface methodology: Antiangiogenic activity study. Protein Expr. Purif.
2013, 90, 55–66. [CrossRef] [PubMed]
126. Abdel-Fattah, Y.R.; Olama, Z.A. L-asparaginase production by Pseudomonas aeruginosa in solid-state culture:
Evaluation and optimization of culture conditions using factorial designs. Process Biochem. 2002, 38, 115–122.
[CrossRef]
127. Meriem, G.; Mahmoud, K. Optimization of chitinase production by a new Streptomyces griseorubens C9 isolate
using response surface methodology. Ann. Microbiol. 2017, 67, 175–183. [CrossRef]
128. Ghosh, S.; Murthy, S.; Govindasamy, S.; Chandrasekaran, M. Optimization of L-asparaginase production
by Serratia marcescens (NCIM 2919) under solid state fermentation using coconut oil cake. Sustain. Chem.
Process 2013, 1, 9. [CrossRef]
129. Woods, D.C.; Lewis, S.M. Design of Experiments for Screening. In Handbook of Uncertainty Quantification;
Springer: Cham, Switzerland, 2015; pp. 1–43.
130. Dey, S.S.; Dora, K.C. Optimization of the production of shrimp waste protein hydrolysate using microbial
proteases adopting response surface methodology. J. Food Sci. Technol. 2014, 51, 16–24. [CrossRef] [PubMed]
131. Myers, R.; Montgomery, D.; Vining, G.G.; Borror, C.; Kowalski, S. Response Surface Methodology:
A Retrospective and Literature Survey. J. Qual. Technol. 2004, 36, 53–77. [CrossRef]
132. Dadzie, R.G.; Ma, H.; Abano, E.E.; Qu, W.; Mao, S. Optimization of process conditions for production of
angiotensin I-converting enzyme (ACE) inhibitory peptides from vital wheat gluten using response surface
methodology. Food Sci. Biotechnol. 2013, 22, 1531–1537. [CrossRef]
133. Thakkar, A.; Saraf, M. Application of Statistically Based Experimental Designs to Optimize Cellulase
Production and Identification of Gene. Nat. Prod. Bioprospect. 2014, 4, 341–351. [CrossRef] [PubMed]
134. Garai, D.; Kumar, V. Response surface optimization for xylanase with high volumetric productivity by
indigenous alkali tolerant Aspergillus candidus under submerged cultivation. 3 Biotech 2012, 3, 127–136.
[CrossRef] [PubMed]
135. Khurana, S.; Kapoor, M.; Gupta, S.; Kuhad, R.C. Statistical optimization of alkaline xylanase production
from Streptomyces violaceoruber under submerged fermentation using response surface methodology. Indian J.
Microbiol. 2007, 47, 144–152. [CrossRef] [PubMed]
Bioengineering 2018, 5, 89 25 of 27
136. Morowvat, M.H.; Memari, H.R. Optimization of Fermentation Conditions for Recombinant Human
Interferon Beta Production by Escherichia coli Using the Response Surface Methodology. Jundishapur J.
Microbiol. 2015, 8, 1–8. [CrossRef]
137. Tabandeh, F.; Khodabandeh, M.; Yakhchali, B.; Habib-Ghomi, H.; Shariati, P. Response surface methodology
for optimizing the induction conditions of recombinant interferon beta during high cell density culture.
Chem. Eng. Sci. 2008, 63, 2477–2483. [CrossRef]
138. Anderson-Cook, C.M.; Borror, C.M.; Montgomery, D.C. Response surface design evaluation and comparison.
J. Stat. Plan. Inference 2009, 139, 629–641. [CrossRef]
139. Liu, C.; Sun, Z.T.; Du, J.H.; Wang, J. Response surface optimization of fermentation conditions for producing
xylanase by Aspergillus niger SL-05. J. Ind. Microbiol. Biotechnol. 2008, 35, 703–711. [CrossRef] [PubMed]
140. Behera, S.K.; Meena, H.; Chakraborty, S.; Meikap, B.C. Application of response surface methodology (RSM)
for optimization of leaching parameters for ash reduction from low-grade coal. Int. J. Min. Sci. Technol. 2018,
28, 621–629. [CrossRef]
141. Rani, V.; Dash, S.; Nain, L.; Arora, A. Expression of novel glucose tolerant β-glucosidase on cell surface by
Rhodotorula glutinis isolate. Biocatal. Agric. Biotechnol. 2015, 4, 380–387. [CrossRef]
142. Wang, Y.; Wang, Q.; Wang, Y.; Han, H.; Hou, Y.; Shi, Y. Statistical optimization for the production of
recombinant cold-adapted superoxide dismutase in E. coli using response surface methodology. Bioengineered
2017, 5979, 1–7.
143. Maldonado, L.P.; Hernández, V.E.B.; Rivero, E.M.; Barba de la Rosa, A.P.; Flores, J.L.F.; Acevedo, L.G.O.
Optimization of culture conditions for a synthetic gene expression in Escherichia coli using response surface
methodology: The case of human interferon beta. Biomol. Eng. 2007, 24, 217–222. [CrossRef] [PubMed]
144. Balderas, H.V.E.; Paz Maldonado, L.M.T.; Rivero, E.M.; Barba de la Rosa, A.P.; Ordoñez Acevedo, L.G.;
Rodríguez, A.D.L. Optimization of human interferon gamma production in Escherichia coli by response
surface methodology. Biotechnol. Bioprocess Eng. 2008, 13, 7–13. [CrossRef]
145. Batra, J.; Beri, D.; Mishra, S. Response surface methodology based optimization of β-glucosidase production
from Pichia Pastor. Appl. Biochem. Biotechnol. 2014, 172, 380–393. [CrossRef] [PubMed]
146. Dey, G.; Mitra, A.; Banerjee, R.; Maiti, B.R. Enhanced production of amylase by optimization of nutritional
constituents using response surface methodology. Biochem. Eng. J. 2001, 7, 227–231. [CrossRef]
147. Tanyildizi, M.S.; Özer, D.; Elibol, M. Optimization of α-amylase production by Bacillus sp. using response
surface methodology. Process Biochem. 2005, 40, 2291–2296. [CrossRef]
148. Low, K.O.; Muhammad Mahadi, N.; Abdul Rahim, R.; Rabu, A.; Abu Bakar, F.D.; Murad, A.M.A. An effective
extracellular protein secretion by an ABC transporter system in Escherichia coli: Statistical modeling and
optimization of cyclodextrin glucanotransferase secretory production. J. Ind. Microbiol. Biotechnol. 2011, 38,
1587–1597. [CrossRef] [PubMed]
149. Hao, D.C.; Zhu, P.H.; Yang, S.L.; Yang, L. Optimization of recombinant cytochrome P450 2C9 protein
production in Escherichia coli DH5α by statistically-based experimental design. World J. Microbiol. Biotechnol.
2006, 22, 1169–1176. [CrossRef]
150. Ghoshoon, M.B.; Berenjian, A.; Hemmati, S.; Dabbagh, F.; Karimi, Z.; Negahdaripour, M. Extracellular
Production of Recombinant l-Asparaginase II in Escherichia coli: Medium Optimization Using Response
Surface Methodology. Int. J. Pept. Res. Ther. 2015, 21, 487–495. [CrossRef]
151. Nikerel, I.E.; Toksoy, E.; Kirdar, B.; Yildirim, R. Optimizing medium composition for TaqI endonuclease
production by recombinant Escherichia coli cells using response surface methodology. Process Biochem. 2005,
40, 1633–1639. [CrossRef]
152. Farliahati, M.R.; Ramanan, R.N.; Mohamad, R.; Puspaningsih, N.N.T.; Ariff, A.B. Enhanced production of
xylanase by recombinant Escherichia coli DH5α through optimization of medium composition using response
surface methodology. Ann. Microbiol. 2010, 60, 279–285. [CrossRef]
153. Muntari, B.; Amid, A.; Mel, M.; Jami, M.S.; Salleh, H.M. Recombinant bromelain production in Escherichia coli:
Process optimization in shake flask culture by response surface methodology. AMB Express 2012, 2.
[CrossRef] [PubMed]
154. Sunitha, K.; Lee, J.K.; Oh, T.K. Optimization of medium components for phytase production by E. coli using
response surface methodology. Bioprocess Eng. 1999, 21, 477–481. [CrossRef]
Bioengineering 2018, 5, 89 26 of 27
155. Lee, Y.J.; Kim, H.J.; Gao, W.; Chung, C.H.; Lee, J.W. Statistical optimization for production of
carboxymethylcellulase of Bacillus amyloliquefaciens DL-3 by a recombinant Escherichia coli JM109/DL-3
from rice bran using response surface method. Biotechnol. Bioprocess Eng. 2012, 17, 227–235. [CrossRef]
156. Joshi, S.; Satyanarayana, T. Optimization of heterologous expression of the phytase (PPHY) of Pichia anomala
in P. pastoris and its applicability in fractionating allergenic glycinin from soy protein. J. Ind. Microbiol.
Biotechnol. 2014, 41, 977–987. [PubMed]
157. Chen, Y.; Xing, X.H.; Ye, F.; Kuang, Y.; Luo, M. Production of MBP–HepA fusion protein in recombinant
Escherichia coli by optimization of culture medium. Biochem. Eng. J. 2007, 34, 114–121. [CrossRef]
158. Pan, H.; Xie, Z.; Bao, W.; Zhang, J. Optimization of culture conditions to enhance cis-epoxysuccinate
hydrolase production in Escherichia coli by response surface methodology. Biochem. Eng. J. 2008, 42, 133–138.
[CrossRef]
159. Karimineghlani, P.; Neghlani, P.K.; Azadmehr, A. Optimization of lead ions adsorption on hydrolyzed
polyacrylonitrile fibers using central composite design. Desalination Water Treat. 2017, 83, 133–143. [CrossRef]
160. Almeida, J.M.; Lima, V.A.; Giloni-Lima, P.C.; Knob, A. Passion fruit peel as novel substrate for enhanced
beta-glucosidases production by Penicillium verruculosum: Potential of the crude extract for biomass
hydrolysis. Biomass Bioenergy 2015, 72, 216–226. [CrossRef]
161. Singh, A.K.; Chhatpar, H.S. Optimization of protease production by Streptomyces sp. A6 using statistical
approach for reclamation of shellfish waste. World J. Microbiol. Biotechnol. 2010, 26, 1631–1639. [CrossRef]
162. Khataee, A.R. Application of central composite design for the optimization of photo-destruction of a textile
dye using UV/S2O82-process. Pol. J. Chem. Technol. 2009, 11, 38–45. [CrossRef]
163. Nelofer, R.; Ramanan, R.N.; Rahman, R.A.; Basri, M.; Ariff, A.B. Comparison of the estimation capabilities
of response surface methodology and artificial neural network for the optimization of recombinant lipase
production by E. coli BL21. J. Ind. Microbiol. Biotechnol. 2012, 39, 243–254. [CrossRef] [PubMed]
164. Vellanki, R.N.; Potumarthi, R.; Mangamoori, L.N. Constitutive expression and optimization of nutrients for
streptokinase production by pichia pastoris using statistical methods. Appl. Biochem. Biotechnol. 2009, 158,
25–40. [CrossRef] [PubMed]
165. Sharma, L.; Kumar, S.A.; Panda, B.; Mallick, N. Process optimization for poly-β-hydroxybutyrate production
in a nitrogen fixing cyanobacterium, Nostoc muscorum using response surface methodology. Bioresour.
Technol. 2007, 98, 987–993. [CrossRef] [PubMed]
166. Tatineni, R.; Doddapaneni, K.K.; Potumarthi, R.C.; Mangamoori, L.N. Optimization of keratinase production
and enzyme activity using response surface methodology with streptomyces sp7. Appl. Biochem. Biotechnol.
2007, 141, 187–201. [CrossRef] [PubMed]
167. Pareek, N.; Ghosh, S.; Singh, R.P.; Vivekanand, V. Mustard oil cake as an inexpensive support for production
of chitin deacetylase by Penicillium oxalicum SAEM-51 under solid-state fermentation. Biocatal. Agric.
Biotechnol. 2014, 3, 212–217. [CrossRef]
168. Tavakkoli, M.; Hamidi-Esfahani, Z.; Azizi, M.H. Optimization of Corynebacterium glutamicum Glutamic
Acid Production by Response Surface Methodology. Food Bioprocess Technol. 2012, 5, 92–99. [CrossRef]
169. Almeida, M.; Erthal, R.; Padua, E.; Silveira, L.; Am, L. Response surface methodology (RSM) as a tool for
optimization in analytical chemistry. Talanta 2008, 76, 965–977.
170. Nagar, S.; Gupta, V.K.; Kumar, D.; Kumar, L.; Kuhad, R.C. Production and optimization of cellulase-free,
alkali-stable xylanase by Bacillus pumilus SV-85S in submerged fermentation. J. Ind. Microbiol. Biotechnol.
2010, 37, 71–83. [CrossRef] [PubMed]
171. Li, X.; Xu, T.; Ma, X.; Guo, K.; Kai, L.; Zhao, Y. Optimization of culture conditions for production of
cis-epoxysuccinic acid hydrolase using response surface methodology. Bioresour. Technol. 2008, 99, 5391–5396.
[CrossRef] [PubMed]
172. Ray, R.C.; Kar, S. Statistical optimization of [alpha]-amylase production by Bacillus brevis MTCC 7521 in
solid-state fermentation using cassava bagasse. Biologia 2009, 64, 864–870. [CrossRef]
173. Rekha, V.P.B.; Ghosh, M.; Adapa, V.; Oh, S.J.; Pulicherla, K.K.; Sambasiva Rao, K.R.S. Optimization of
polygalacturonase production from a newly isolated Thalassospira frigidphilosprofundus to use in pectin
hydrolysis: Statistical approach. Biomed Res. Int. 2013. [CrossRef] [PubMed]
174. Deswal, A.; Deora, N.S.; Mishra, H.N. Optimization of Enzymatic Production Process of Oat Milk Using
Response Surface Methodology. Food Bioprocess Technol. 2014, 7, 610–618. [CrossRef]
Bioengineering 2018, 5, 89 27 of 27
175. Halmi, M.I.E.; Abdullah, S.R.S.; Wasoh, H.; Johari, W.L.W.; Ali, M.S.; Shaharuddin, N.A. Optimization and
maximization of hexavalent molybdenum reduction to Mo-blue by Serratia sp. strain MIE2 using response
surface methodology. Rend. Lincei 2016, 27, 697–709. [CrossRef]
176. Khoshayand, F.; Goodarzi, S.; Shahverdi, A.R.; Khoshayand, M.R. Optimization of Culture Conditions for
Fermentation of Soymilk Using Lactobacillus casei by Response Surface Methodology. Probiotics Antimicrob.
Proteins 2011, 3, 159–167. [CrossRef] [PubMed]
177. Cui, F.; Liu, Z.; Li, Y.; Ping, L.; Ping, L.; Zhang, Z. Production of mycelial biomass and exo-polymer by
Hericium erinaceus CZ-2: Optimization of nutrients levels using response surface methodology. Biotechnol.
Bioprocess Eng. 2010, 15, 299–2307. [CrossRef]
178. Partida-Sedas, G.; Montes-García, N.; Carvajal-Zarrabal, O.; López-Zamora, L.; Gómez-Rodríguez, J.;
Aguilar-Uscanga, M.G. Optimization of Hydrolysis Process to Obtain Fermentable Sugars from Sweet
Sorghum Bagasse Using a Box–Behnken Design. Sugar Tech 2017, 19, 317–325. [CrossRef]
179. Rajendran, A.; Thangavelu, V. Optimization and Modeling of Process Parameters for Lipase Production by
Bacillus Brevis. Food Bioprocess Technol. 2012, 5, 310–322. [CrossRef]
© 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
